Literature DB >> 31084358

Advanced Oxidation Protein Products Promote Lipotoxicity and Tubulointerstitial Fibrosis via CD36/β-Catenin Pathway in Diabetic Nephropathy.

Xiao Li1, Ting Zhang2, Jian Geng3, Zhuguo Wu4, Liting Xu2, Jixing Liu2, Jianwei Tian2, Zhanmei Zhou2, Jing Nie2, Xiaoyan Bai2.   

Abstract

Aims: Diabetic nephropathy (DN) is the principal cause of mortality and morbidity in diabetic patients, the progression of which correlates best with tubulointerstitial fibrosis (TIF). Advanced oxidation protein products (AOPPs) have been detected in patients with chronic renal failure, causing injuries to proximal tubular epithelial cells. CD36, a known receptor for AOPP, is an important modulator of lipid homeostasis, predisposing to renal tubular damage. However, whether AOPPs induce lipotoxicity via the CD36 receptor pathway remains unknown. Herein, we tested the hypothesis that AOPPs accumulation in diabetes incurs lipotoxicity, causing renal TIF via the CD36 signaling pathway.
Results: In DN patients and diabetic mice in vivo, AOPPs overload induces lipogenesis (upregulation of CD36 and sterol regulatory element-binding protein 1), fibrosis (upregulation of Fibronectin), and renal function decline (increased serum creatinine and N-acetyl-β-d-glucosaminidase, decreased estimated glomerular filtration rate). In HK-2 cells in vitro, high glucose stimulated AOPPs-induced lipotoxicity, apoptosis, and fibrosis via the CD36 receptor pathway. In addition, apocynin abrogated AOPPs-induced lipid accumulation and CD36 inhibition significantly mitigated AOPPs-induced mitochondrial injuries, lipotoxicity, and renal fibrosis. Further, we provide mechanistic evidence that AOPPs overload induces the enrichment of β-catenin binding the CD36 promoter region. Innovation and
Conclusion: Our data reveal a major role of AOPPs in triggering lipotoxicity and fibrosis via CD36-dependent Wnt/β-catenin activation, providing new evidence for understanding the role of lipid accumulation in DN.

Entities:  

Keywords:  AOPP; CD36; diabetic nephropathy; lipotoxicity; tubulointerstitial fibrosis; β-catenin

Year:  2019        PMID: 31084358     DOI: 10.1089/ars.2018.7634

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  21 in total

1.  Advanced Oxidative Protein Products Role in Multiple Sclerosis: a Systematic Review and Meta-analysis.

Authors:  Patrícia Rodrigues; Guilherme Vargas Bochi; Gabriela Trevisan
Journal:  Mol Neurobiol       Date:  2021-08-15       Impact factor: 5.590

Review 2.  Nutrient sensing, signaling transduction, and autophagy in podocyte injury: implications for kidney disease.

Authors:  Dongqing Zha; Xiaoyan Wu
Journal:  J Nephrol       Date:  2022-06-15       Impact factor: 3.902

3.  SMAD3 promotes autophagy dysregulation by triggering lysosome depletion in tubular epithelial cells in diabetic nephropathy.

Authors:  Chen Yang; Xiao-Cui Chen; Zhi-Hang Li; Hong-Luan Wu; Kai-Peng Jing; Xiao-Ru Huang; Lin Ye; Biao Wei; Hui-Yao Lan; Hua-Feng Liu
Journal:  Autophagy       Date:  2020-10-12       Impact factor: 16.016

Review 4.  Druggability of lipid metabolism modulation against renal fibrosis.

Authors:  Yuan-Yuan Chen; Xiao-Guang Chen; Sen Zhang
Journal:  Acta Pharmacol Sin       Date:  2021-05-14       Impact factor: 6.150

Review 5.  The Cross-Link between Ferroptosis and Kidney Diseases.

Authors:  Jingyu Wang; Yi Liu; Yaqing Wang; Li Sun
Journal:  Oxid Med Cell Longev       Date:  2021-05-03       Impact factor: 6.543

Review 6.  Cellular crosstalk of glomerular endothelial cells and podocytes in diabetic kidney disease.

Authors:  Shan Jiang; Manyu Luo; Xue Bai; Ping Nie; Yuexin Zhu; Hangxi Cai; Bing Li; Ping Luo
Journal:  J Cell Commun Signal       Date:  2022-01-18       Impact factor: 5.908

7.  Calpain-10 drives podocyte apoptosis and renal injury in diabetic nephropathy.

Authors:  Tao Wang; Yanbin Gao; Xiaolei Wang; Yimin Shi; Jiayi Xu; Bingjie Wu; Jiaxin He; Yimeng Li
Journal:  Diabetes Metab Syndr Obes       Date:  2019-09-11       Impact factor: 3.168

8.  Association of Higher Advanced Oxidation Protein Products (AOPPs) Levels in Patients with Diabetic and Hypertensive Nephropathy.

Authors:  Giovanni Conti; Daniela Caccamo; Rossella Siligato; Guido Gembillo; Ersilia Satta; Dario Pazzano; Nicolina Carucci; Antonio Carella; Giuliana Del Campo; Antonino Salvo; Domenico Santoro
Journal:  Medicina (Kaunas)       Date:  2019-10-07       Impact factor: 2.430

Review 9.  Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities.

Authors:  Lucas Opazo-Ríos; Sebastián Mas; Gema Marín-Royo; Sergio Mezzano; Carmen Gómez-Guerrero; Juan Antonio Moreno; Jesús Egido
Journal:  Int J Mol Sci       Date:  2020-04-10       Impact factor: 5.923

Review 10.  The Multifunctionality of CD36 in Diabetes Mellitus and Its Complications-Update in Pathogenesis, Treatment and Monitoring.

Authors:  Kamila Puchałowicz; Monika Ewa Rać
Journal:  Cells       Date:  2020-08-11       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.